Regulatory Effects of Macrolides on Bacterial Virulence: Potential Role as Quorum-Sensing Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
3055-3065
Author(s):
Kazuhiro Tateda, Theodore J. Standiford, Jean Claude Pechere and Keizo Yamaguchi
Cellular and Molecular Effects of Macrolides on Leukocyte Function
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
3067-3080
Author(s):
Marie-Therese Labro
Immunomodulatory Effects of Macrolides in the Lung: Lessons from In- Vitro and In-Vivo Models
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
3081-3093
Author(s):
Wan C. Tsai and Theodore J. Standiford
Rationale for the Development of Cholinesterase Inhibitors as Anti- Alzheimer Agents
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
3111-3119
Author(s):
D. K. Lahiri, J. T. Rogers, N. H. Greig and K. Sambamurti
An Overview of the Current and Novel Drugs for Alzheimers Disease with Particular Reference to Anti-Cholinesterase Compounds
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
3121-3130
Author(s):
Marcela Colombres, Juan Paulo Sagal and Nibaldo C. Inestrosa
New Classes of AChE Inhibitors with Additional Pharmacological Effects of Interest for the Treatment of Alzheimers Disease
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
3177-3184
Author(s):
M. Villarroya, A. G. García and J. L. Marco
Preface [Hot Topic: Antimycobacterial Drugs: Current Status and Future Prospects (Executive Editor: Haruaki Tomioka)]
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
iv-iv
Author(s):
Haruaki Tomioka
Adjunctive Immunotherapy of Mycobacterial Infections
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
3297-3312
Author(s):
Haruaki Tomioka
From the Editors Perspective: Aquaporins to Apoptosis
Journal:
Current Neurovascular Research
Volume:
1
Page:
291-291
Author(s):
Kenneth Maiese
Regulation of Endothelial Cell Death and Its Role in Angiogenesis and Vascular Regression
Journal:
Current Neurovascular Research
Volume:
1
Page:
305-315
Author(s):
Kazuhiro Sakamaki